These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 7689030)
1. [Inhibition of human immunodeficiency virus replication by azidothymidine (Azitidín Lachema) in cultured cells]. Schmidtmayerová H; Mayer V Bratisl Lek Listy; 1993 Feb; 94(2):76-80. PubMed ID: 7689030 [TBL] [Abstract][Full Text] [Related]
2. Failure of azidothymidine to inhibit human immunodeficiency virus (HIV) replication in a promonocytic cell line (U937). Uherová P; Schmidtmayerová H; Mayer V Acta Virol; 1991 Aug; 35(4):357-64. PubMed ID: 1724875 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of replication and cytopathic effect of human T cell lymphotropic virus type III/lymphadenopathy-associated virus by 3'-azido-3'-deoxythymidine in vitro. Nakashima H; Matsui T; Harada S; Kobayashi N; Matsuda A; Ueda T; Yamamoto N Antimicrob Agents Chemother; 1986 Dec; 30(6):933-7. PubMed ID: 2434024 [TBL] [Abstract][Full Text] [Related]
4. Resumption of virus production after human immunodeficiency virus infection of T lymphocytes in the presence of azidothymidine. Smith MS; Brian EL; Pagano JS J Virol; 1987 Dec; 61(12):3769-73. PubMed ID: 2446006 [TBL] [Abstract][Full Text] [Related]
5. Mismatched double-stranded RNA (ampligen) reduces concentration of zidovudine (azidothymidine) required for in-vitro inhibition of human immunodeficiency virus. Mitchell WM; Montefiori DC; Robinson WE; Strayer DR; Carter WA Lancet; 1987 Apr; 1(8538):890-2. PubMed ID: 2882293 [TBL] [Abstract][Full Text] [Related]
6. Decreased in vitro susceptibility to zidovudine of HIV isolates obtained from patients with AIDS. Land S; Terloar G; McPhee D; Birch C; Doherty R; Cooper D; Gust I J Infect Dis; 1990 Feb; 161(2):326-9. PubMed ID: 2299212 [TBL] [Abstract][Full Text] [Related]
7. Effect of 3'-azido-2',3'-dideoxythymidine (AZT) and neutralizing antibody on human immunodeficiency virus (HIV)-induced cytopathic effects: implication of giant cell formation for the spread of virus in vivo. Nakashima H; Tochikura T; Kobayashi N; Matsuda A; Ueda T; Yamamoto N Virology; 1987 Jul; 159(1):169-73. PubMed ID: 3111083 [TBL] [Abstract][Full Text] [Related]
8. A rapid and simple colorimetric test for the study of anti-HIV agents. Schwartz O; Henin Y; Marechal V; Montagnier L AIDS Res Hum Retroviruses; 1988 Dec; 4(6):441-8. PubMed ID: 2464361 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of 3'azido-3'deoxythymidine-resistant HIV-1 infection by dehydroepiandrosterone in vitro. Yang JY; Schwartz A; Henderson EE Biochem Biophys Res Commun; 1994 Jun; 201(3):1424-32. PubMed ID: 8024587 [TBL] [Abstract][Full Text] [Related]
10. Highly specific inhibition of human immunodeficiency virus type 1 by a novel 6-substituted acyclouridine derivative. Baba M; Tanaka H; De Clercq E; Pauwels R; Balzarini J; Schols D; Nakashima H; Perno CF; Walker RT; Miyasaka T Biochem Biophys Res Commun; 1989 Dec; 165(3):1375-81. PubMed ID: 2575380 [TBL] [Abstract][Full Text] [Related]
11. Ribavirin antagonizes the effect of azidothymidine on HIV replication. Vogt MW; Hartshorn KL; Furman PA; Chou TC; Fyfe JA; Coleman LA; Crumpacker C; Schooley RT; Hirsch MS Science; 1987 Mar; 235(4794):1376-9. PubMed ID: 2435003 [TBL] [Abstract][Full Text] [Related]
12. Recombinant human interferon-beta suppresses the replication of HIV and acts synergistically with AZT. Williams GJ; Colby CB J Interferon Res; 1989 Dec; 9(6):709-18. PubMed ID: 2514233 [TBL] [Abstract][Full Text] [Related]
13. Alpha-lipoic acid is an effective inhibitor of human immuno-deficiency virus (HIV-1) replication. Baur A; Harrer T; Peukert M; Jahn G; Kalden JR; Fleckenstein B Klin Wochenschr; 1991 Oct; 69(15):722-4. PubMed ID: 1724477 [TBL] [Abstract][Full Text] [Related]
14. [Study of anti-HIV activity of azidothymidine and fluorothymidine 5'-phosphonates]. Mamaeva OA; Pliasunova OA; Pokrovskiĭ AG; Diatkina NB; Arzumanova AA Mol Biol (Mosk); 1994; 28(1):137-42. PubMed ID: 8145741 [TBL] [Abstract][Full Text] [Related]
15. Synergistic inhibition of human immunodeficiency virus type 1 replication by 5-ethyl-1-ethoxymethyl-6-(phenylthio)uracil (E-EPU) and azidothymidine in vitro. Baba M; Ito M; Shigeta S; Tanaka H; Miyasaka T; Ubasawa M; Umezu K; Walker RT; De Clercq E Antimicrob Agents Chemother; 1991 Jul; 35(7):1430-3. PubMed ID: 1929304 [TBL] [Abstract][Full Text] [Related]
16. De novo reverse transcription is a crucial event in cell-to-cell transmission of human immunodeficiency virus. Li P; Kuiper LJ; Stephenson AJ; Burrell CJ J Gen Virol; 1992 Apr; 73 ( Pt 4)():955-9. PubMed ID: 1378883 [TBL] [Abstract][Full Text] [Related]
17. Synergistic drug interactions of an HIV-1 protease inhibitor with AZT in different in vitro models of HIV-1 infection. Lambert DM; Bartus H; Fernandez AV; Bratby-Anders C; Leary JJ; Dreyer GB; Metcalf BW; Petteway SR Antiviral Res; 1993 Aug; 21(4):327-42. PubMed ID: 7692816 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of the in vitro infectivity and cytopathic effect of human foamy virus by dideoxynucleosides. Santillana-Hayat M; Valla J; Canivet M; Peries J; Molina JM AIDS Res Hum Retroviruses; 1996 Oct; 12(15):1485-90. PubMed ID: 8893056 [TBL] [Abstract][Full Text] [Related]
19. AZT (zidovudine) may act postintegrationally to inhibit generation of HIV-1 progeny virus in chronically infected cells. Rooke R; Tremblay M; Wainberg MA Virology; 1990 May; 176(1):205-15. PubMed ID: 1691885 [TBL] [Abstract][Full Text] [Related]
20. Heterogeneity of HIV-1 replication and antigen expression in EBV-transformed B cell lines. Tremblay M; Fitz-Gibbon L; Wainberg MA Leukemia; 1988 Dec; 2(12 Suppl):233S-240S. PubMed ID: 2849000 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]